Gantanol (Sulfamethoxazole) Drug Information: Clinical Pharmacology

Pill Identifier Search

May 27, 2012

Gantanol

Urinary Tract Infection (UTI In Adults) »

Urinary tract infection (UTI) facts

Urinary tract infections (UTIs) are infections of the urethra, bladder, ureters, or the kidneys, which comprise the urinary tract.
E. coli bacteria cause the majority of UTIs, but many other bacteria, fungi, and parasites may also cause UTIs.
Females have a higher risk for UTIs than most males, probably because of their anatomy; other risk factors for UTIs include any condition that may impede urine flow (e.g., enlarged prostate, congenital urinary tract abnormalities, and inflammation). Patients with catheters or those who undergo urinary surgery and men with enlarged prostates are at higher risk for UTIs.
Symptoms and signs of UTI vary somewhat depending on sex, age, and the area of the urinary tract that is infected; some unique symptoms develop depending on the infecting agent.
UTIs are diagnosed usually by isolating and identifying the urinary pathogen from the patient; there a...

Read the Urinary Tract Infection (UTI In Adults) article »

Gantanol

Adult Skin Problems Slideshow Pictures

How Smoking Affects Your Looks Slideshow Pictures

Weight Gain Shockers Slideshow

font size

Please Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

CLINICAL PHARMACOLOGY

Sulfamethoxazole is rapidly absorbed following oral administration. It exists in the blood as unbound, protein-bound, metabolized and conjugated forms. The metabolism of sulfamethoxazole occurs predominately by N₄-acetylation, although the glucuronide conjugate has been identified. The free form is considered to be the therapeutically active form. Approximately 70% of sulfamethoxazole is bound to plasma proteins; of the unbound portion, 80% to 90% is in the nonacetylated form.

Following a single 1-g oral dose in 12 volunteer male subjects, the mean peak plasma concentration of 38 µg/mL of intact sulfamethoxazole was achieved by 2 hours. The mean half-life of sulfamethoxazole is approximately 10 hours. However, patients with severe-ly impaired renal function, as shown by a creatinine clearance of less than 30 mL/minute, exhibit an increase in the half-life of sulfamethoxazole, requiring dosage regimen adjustment.

Sulfamethoxazole is excreted primarily by the kidneys chiefly through glomerular filtration but also through tubular secretion. Urine concentrations of sulfamethoxazole are considerably higher than are the concentrations in blood. Eighty percent to 100% of the dose is excreted in the urine as total sulfamethoxazole, of which 30% is intact drug with the remaining as the N₄-acetylated metabolite.

Sulfamethoxazole diffuses into cerebrospinal fluid, with peak concentrations occurring at 8 hours and reaching approximately 14% of simultaneous plasma concentrations. The drug has also been shown to distribute to aqueous humor, vaginal fluid and middle ear fluid; it also passes the placental barrier and is excreted in breast milk.

Microbiology

The systemic sulfonamides are bacteriostatic agents and the spectrum of activity is similar for all. Sulfonamides inhibit bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA). Resistant strains are capable of utilizing folic acid precursors or preformed folic acid.

Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.